Khalid Ayidh Alotaibi

Khalid Ayidh Alotaibi

Auto-generated profile, based on publicly available information

Khalid Ayidh Alotaibi

Orthopedics Department, Alhada Armed Force Hospital, Taif, Saudi Arabia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Orthopedic Research and Reviews
Verified
Journal Article
Open access
PDF file
SSSuliman Abdullah Shurbaji
Suliman Abdullah Shurbaji
AAAbdulaziz Ahmed Abdulaziz
Abdulaziz Ahmed Abdulaziz
OAObaidallah Buraykan Alsuwat
Obaidallah Buraykan Alsuwat
SASaleh Mohammad Abu Adas
Saleh Mohammad Abu Adas
KAKhalid Ayidh Alotaibi
Khalid Ayidh Alotaibi
AAAli Mohammed Alahmari
Ali Mohammed Alahmari
Background: Congenital talipes equinovarus (CTEV), continues to rank among the most common congenital musculoskeletal deformities. The management of CTEV, particularly when it is part of a syndromic presentation or associated with conditions such as myelomeningocele (MMC), presents a significant challenge due to the deformity’s tendency to be stiffer and more complex. Most children with CTEV may require surgical intervention. The current case report highlights the functional outcome of minimally invasive percutaneous surgical correction in a late-presenting, rigid, and severe foot deformity in an MMC patient, aiming to have accepted residual deformity that gave better function with less surgical complication. Methods: A case involving an eight-year-old girl having a deformity in her left foot secondary to low lumbar level MMC was referred for management. The Pirani score total was 6, signifying a severe deformity according to received initial assessments. Upon review of treatment alternatives, minimally invasive percutaneous surgical correction was performed consisting of percutaneous plantar fascia release followed by Achilles tendon lengthening and flexor digitorum tenotomy. We followed up with the patient for one year for wound healing and functional outcomes. An early weight bearing in cast was achieved 1 week with walker frame. Removal of cast and application of custom walker orthosis for walking on the 6th week post-operation. Following up to one year, she is a walker, and residual deformity of the foot did not affect her mobilization. Results: As of the one-year follow-up, she is self-ambulatory, thanks to her custom walking orthosis. Residual deformity did not affect her functional outcome. We recommend further follow-up, and future surgery may be necessary if her deformity worsens. Conclusion: The functional outcome, the social and economic status of the family, and the psychological impact on the patient significantly influence the selection of the most suitable method.

2 November 2026 in BMC Cancer
Verified
Journal Article
Open access
ADAlbara Dabroom
Albara Dabroom
MAMuhanad Saleh Alzahrani
Muhanad Saleh Alzahrani
AAAbdullah Alabbasi
Abdullah Alabbasi
KAKhalid Alotaibi
Khalid Alotaibi
FSFaris Sultan
Faris Sultan
IAIbrahim Alshaygy
Ibrahim Alshaygy
Background: Evidence for neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in primary bone sarcoma is dominated by osteosarcoma and has been affected by inconsistent endpoint and effect-size extraction. We re-extracted eligible estimates from the primary reports and evaluated their independent prognostic associations. Methods: MEDLINE, Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched for cohort studies reporting pretreatment NLR, PLR, or LMR in primary bone sarcoma. The primary analysis required clinically multivariable-adjusted, categorical high-versus-low hazard ratios (HRs). Overall survival (OS) was analyzed separately from progression-free survival (PFS), disease-free survival (DFS), event-free survival (EFS), and disease-specific mortality. Random-effects models used restricted maximum likelihood (REML) estimation and Hartung-Knapp confidence intervals. Histology- and Newcastle-Ottawa Scale (NOS)-based subgroup analyses were prespecified when at least two studies were available. Results: Ten studies remained in the systematic review, and nine contributed at least one source-verifiable endpoint-specific adjusted estimate to quantitative synthesis. Seven NLR-OS cohorts yielded a pooled HR of 1.64 (95% CI 1.15–2.33; I² = 81.4%). The osteosarcoma-only subgroup remained significant (five cohorts; HR 1.70, 95% CI 1.03–2.81; I² = 86.6%). Excluding Huang X 2019 from the strict dataset yielded HR 1.84 (95% CI 1.44–2.36; I² = 0%); the reviewer-specified comparison against the previous eight-estimate set, retaining Yang Q 2020 only as a source-reported sensitivity input, yielded HR 1.90 (95% CI 1.47–2.45; I² = 5.9%). PLR was not associated with OS (four cohorts; HR 1.07, 95% CI 0.67–1.72; I² = 56.0%). LMR showed a non-significant protective trend (three cohorts; HR 0.70, 95% CI 0.38–1.27; I² = 0%). Conclusions: Higher pretreatment NLR is associated with poorer OS, including in the strict osteosarcoma-only analysis. The direction remained stable in every leave-one-out analysis, while the marked reduction in heterogeneity after excluding Huang X 2019 identifies one dominant statistical influence. Retrospective designs and residual heterogeneity limit clinical application. PLR and LMR findings remain inconclusive, and whether NLR-guided management improves outcomes is untested.